We are live on ! Find out more
IBT

International Biotechnology Trust Portfolio holdings

AUM $297M
1-Year Est. Return 17.25%
This Fund
S&P 500
This Quarter Est. Return
-9.61%
1 Year Est. Return
+17.25%
3 Year Est. Return
+11.14%
5 Year Est. Return
+79.35%
10 Year Est. Return
–
AUM
$216M
AUM Growth
-$53.3M
Cap. Flow
-$20.8M
Cap. Flow %
-9.59%
Top 10 Hldgs %
56.68%
Holding
66
New
2
Increased
13
Reduced
15
Closed
8

Top Buys

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$4.88M
2
CELG
Celgene Corp
CELG
+$2.71M
3
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$2.33M
4
SGMO
SANGAMO THERAPEUTICS INC
SGMO
+$2.24M
5
AMRN
Amarin Corp
AMRN
+$2.13M

Top Sells

Rank Stock Value
1
HALO icon
Halozyme
HALO
+$6.97M
2
EXEL icon
Exelixis
EXEL
+$6.88M
3
GTHX
G1 Therapeutics, Inc. Common Stock
GTHX
+$4.25M
4
SAGE
Sage Therapeutics
SAGE
+$3.01M
5
BIIB icon
Biogen
BIIB
+$2.56M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SUPN icon
51
Supernus Pharmaceuticals
SUPN
$2.57B
$548K 0.25%
19,953
– –
AKCA
52
DELISTED
Akcea Therapeutics Inc
AKCA
$488K 0.23%
31,723
– –
FOLD
53
DELISTED
Amicus Therapeutics
FOLD
$470K 0.22%
58,600
– –
RDUS
54
DELISTED
Radius Health, Inc.
RDUS
$437K 0.2%
17,000
– –
ANAB icon
55
AnaptysBio
ANAB
$1.7B
$350K 0.16%
+10,000
New +$476K
ARQL
56
DELISTED
Arqule Inc
ARQL
$294K 0.14%
41,000
-198,103
-83% -$1.86M
GTHX
57
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$255K 0.12%
11,200
-134,800
-92% -$4.25M
DERM
58
DELISTED
Dermira, Inc.
DERM
$191K 0.09%
30,000
– –
ALKS icon
59
Alkermes
ALKS
$8.2B
– –
-70,000
Closed -$1.58M
IOVA icon
60
Iovance Biotherapeutics
IOVA
$3.74B
– –
-104,000
Closed -$2.54M
LGND icon
61
Ligand Pharmaceuticals
LGND
$5.67B
– –
-11,702
Closed -$833K
PRQR icon
62
ProQR Therapeutics
PRQR
$327M
– –
-56,000
Closed -$511K
TVTX icon
63
Travere Therapeutics
TVTX
$6.36B
– –
-18,000
Closed -$362K
CNCE
64
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
– –
-70,000
Closed -$839K
XENT
65
DELISTED
Intersect ENT, Inc
XENT
– –
-96,000
Closed -$2.18M
BHVN
66
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
– –
-50,949
Closed -$2.23M
1 2
3

Similar funds

DCMIC
Decheng Capital Management III (Cayman) Grand Cayman, Cayman Islands $300M AUM 15.74% 1-Year Est. Return
DT
Daniels + Tansey Wilmington, Delaware $289M AUM 18.06% 1-Year Est. Return
3LCM
3D/L Capital Management Hartford, Connecticut $308M AUM 13.67% 1-Year Est. Return
TFA
Triad Financial Advisors Greensboro, North Carolina $284M AUM 14.95% 1-Year Est. Return
SFG
Steward Financial Group Colleyville, Texas $315M AUM 13.78% 1-Year Est. Return
AEPLI
AH Equity Partners LSV I Menlo Park, California $315M AUM 9.31% 1-Year Est. Return
CC
Chanos & Company New York $318M AUM 4.62% 1-Year Est. Return
BC
Brahman Capital New York $275M AUM 18.08% 1-Year Est. Return

International Biotechnology Trust's Q3 2019 Portfolio in Review

As of Q3 2019, International Biotechnology Trust held 66 positions worth $216M, down 20% from $270M the previous quarter. Its ten largest holdings account for 57% of the portfolio.

International Biotechnology Trust withdrew a net $20.8M in Q3 2019, closing 8 positions and reducing 15 holdings. Its most notable exit was Iovance Biotherapeutics, an estimated $2.54M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

Against the trend, International Biotechnology Trust opened a new position in Deciphera Pharmaceuticals, Inc. Common Stock worth $577K.

  • International Biotechnology Trust's largest Q3 2019 buy was Deciphera Pharmaceuticals, Inc. Common Stock: 17,000 shares worth $577K.
  • International Biotechnology Trust added most to Regeneron Pharmaceuticals in Q3 2019, an estimated $4.88M increase.
  • International Biotechnology Trust's biggest Q3 2019 reduction was Halozyme, cutting an estimated $6.97M.
  • International Biotechnology Trust fully exited Iovance Biotherapeutics in Q3 2019, selling an estimated $2.54M.
  • International Biotechnology Trust's ten largest holdings make up 57% of its $216M portfolio in Q3 2019.
  • International Biotechnology Trust opened 2 new positions and closed 8 in Q3 2019.
  • International Biotechnology Trust's portfolio value fell 20% quarter-over-quarter to $216M.

Based on International Biotechnology Trust's 13F filing for Q3 2019, filed 14 Nov 2019.